Krishnan Mahesh
Halozyme Therapeutics, Inc. · Director
Krishnan Mahesh serves as a Director at Halozyme Therapeutics, Inc., a company known for its innovations in the healthcare sector. His trading activity is documented through SEC Form 4 filings, revealing a focus on sale transactions. Between May 2, 2025, and June 30, 2026, Mahesh reported six disclosures, all related to Halozyme Therapeutics (ticker: HALO), with the largest sale valued at $547.8K.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $548k7.3k shares | SellJun 29, 2026 | $75.00 | $77.54 |